In todays episode we're going to talk about the approval of Crysvita for tumor-induced osteomalacia and approval of Fintepla for Dravet syndrome. We'll also talk about approval of Phesgo for HER-2 positive breast cancer, and Dojolvi to treat rare genetic disorders that involve long-chain fatty acid oxidation. Don't forget to like, share and subscribe! Enjoy!